University of Texas Southwestern Simmons Comprehensive Cancer Center

Dallas, Texas 75235

We've found

1 trials

at this facility

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Dallas, TX

Use our guide to learn which trials are right for you!